Updated Jul. 6, 2012 at 2:48 p.m.

Premium Lock Biotech firm Biolex, which raised $160M, seeks bankruptcy

Published: 2012-07-06 14:44:00
Updated: 2012-07-06 14:48:27

Biolex worker eyes lemna plants. Biolex worker eyes lemna plants. (Biolex photo) Image 1 of 3 · Next Image…

The biotechnology firm, backed by Intersouth Partners which is owed some $5 million, has been seeking to development treatments for hepatitis C. Biolex raised $60 million in 2008 in one of the state's biggest venture capital deals. It tried and failed to go public that same year....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll